SARANDÖL, E. Et Al. 2023. Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome. Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry , vol.15, no.1 , 46-52.

SARANDÖL, E., DEMİRCİ AKGÜN, M., SARANDÖL, A., & GÜR, E., (2023). Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome. Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry , vol.15, no.1, 46-52.

SARANDÖL, EMRE Et Al. "Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome," Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry , vol.15, no.1, 46-52, 2023

SARANDÖL, EMRE Et Al. "Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome." Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry , vol.15, no.1, pp.46-52, 2023

SARANDÖL, E. Et Al. (2023) . "Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome." Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry , vol.15, no.1, pp.46-52.

@article{article, author={EMRE SARANDÖL Et Al. }, title={Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome}, journal={Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry}, year=2023, pages={46-52} }